These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12109702)
41. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres. Sinha VR; Trehan A Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842 [TBL] [Abstract][Full Text] [Related]
42. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment. Pagar KP; Vavia PR Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187 [TBL] [Abstract][Full Text] [Related]
43. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Cohen S; Yoshioka T; Lucarelli M; Hwang LH; Langer R Pharm Res; 1991 Jun; 8(6):713-20. PubMed ID: 2062800 [TBL] [Abstract][Full Text] [Related]
44. Nanofibrous bicomponent scaffolds for the dual delivery of NGF and GDNF: controlled release of growth factors and their biological effects. Liu C; Li X; Zhao Q; Xie Y; Yao X; Wang M; Cao F J Mater Sci Mater Med; 2021 Jan; 32(1):9. PubMed ID: 33471206 [TBL] [Abstract][Full Text] [Related]
46. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Wang J; Wang BM; Schwendeman SP Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856 [TBL] [Abstract][Full Text] [Related]
47. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Uchida T; Yagi A; Oda Y; Nakada Y; Goto S Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042 [TBL] [Abstract][Full Text] [Related]
48. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate). Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139 [TBL] [Abstract][Full Text] [Related]
49. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
50. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765 [TBL] [Abstract][Full Text] [Related]
55. Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCs. Rong X; Yang S; Miao H; Guo T; Wang Z; Shi W; Mo X; Yuan W; Jin T Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6025-34. PubMed ID: 22871834 [TBL] [Abstract][Full Text] [Related]
56. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres. Takada S; Kurokawa T; Miyazaki K; Iwasa S; Ogawa Y Pharm Res; 1997 Sep; 14(9):1146-50. PubMed ID: 9327440 [TBL] [Abstract][Full Text] [Related]
57. Local delivery of controlled released nerve growth factor promotes sciatic nerve regeneration after crush injury. Yu H; Liu J; Ma J; Xiang L Neurosci Lett; 2014 Apr; 566():177-81. PubMed ID: 24614335 [TBL] [Abstract][Full Text] [Related]